Multiple Sclerosis and Neuroinflammation
Multiple sclerosis (MS) is a disease of the central nervous system (i.e., the brain and the spinal cord) in which inflammation causes damage to nerve cells (neurons) and the myelin sheath which surrounds them. Initially there is good repair of the damage caused by inflammation, allowing for good clinical recovery. However, over time, such repair and clinical recovery tend to become incomplete and lead to various degrees of disability.
The MS service is based at the QMC.
It is led by a multidisciplinary team including neurology and neurorehabilitation consultants, specialist nurses, neurophysiotherapists, and occupational therapists.
Over 2,800 patients are regularly seen in our clinics.
We also provide Disease Modifying Treatments (DMTs) including Interferon-beta in all its available formulations, Glatiramer acetate, Teriflunomide, Dimethylfumarate, Fingolimod, Natalizumab, Alemtuzumab, Cladribine, and Ocrelizumab. DMTs are aimed at reducing inflammation in the brain and spinal cord and the accumulation of neurological impairment over time.
Our Neuroimmunology clinics treat patients with other diseases of the nervous system caused by a dysfunction of the immune system. These include, for example, nervous system vasculitis, sarcoidosis, and Behcet's disease.
MS Nurse-led clinics - 0115 875 4605